Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
January-2020 Volume 19 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2020 Volume 19 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Increase in liver γδ T cells with concurrent augmentation of IFN‑β production during the early stages of a mouse model of acute experimental hepatitis B virus infection

  • Authors:
    • Lin Chang
    • Lei Wang
    • Ning Ling
    • Hui Peng
    • Min Chen
  • View Affiliations / Copyright

    Affiliations: Department of Clinical Laboratory, People's Hospital of Bishan District, Chongqing 402760, P.R. China, Department of Clinical Laboratory, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University, Chongqing 400016, P.R. China, Department of Clinical Laboratory, The Second Affiliated Hospital, Chongqing Medical University, Chongqing 400010, P.R. China
    Copyright: © Chang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 67-78
    |
    Published online on: November 13, 2019
       https://doi.org/10.3892/etm.2019.8197
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The role of γδ T cells in acute hepatitis B virus (HBV) infection remains unclear. For the present study, a mouse model of acute HBV infection was constructed using hydrodynamic injection‑based transfection of an HBV DNA plasmid (pHBV). Subsequent changes in the percentages of γδ T cells, expression of activation molecules (CD25 and CD69) and the production of the inflammatory cytokines interferon (IFN)‑γ and tumor necrosis factor‑α (TNF‑α) by liver γδ T cells were investigated using fluorescence‑activated cell sorting (FACS). Additionally, the immune responses in the mouse liver were evaluated dynamically by measuring cytokine mRNA expression (IFN‑α, IFN‑β, IFN‑γ or TNF‑α) using reverse transcription‑quantitative PCR, and other populations of immune cells, including CD4+T, CD8+T, natural killer (NK) or natural killer T (NKT) cells, using FACS. On day 1 following acute HBV infection, the percentage of liver γδ T cells was significantly increased along with the high expression of HBV markers. Additionally, liver γδ T cells displayed peak expression of the activation marker CD69 and peak IFN‑γ production within this timeframe. IFN‑β mRNA expression and the percentage of NK cells were elevated significantly on day 1 in liver tissues. However, there were no significant changes in the spleen or peripheral γδ T cells. Therefore, these data suggested that during the early stages of acute HBV infection, significantly increased numbers of liver γδ T cells may be involved in the enhanced immune response to the increased expression of HBV markers in the liver.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Seto WK, Lo YR, Pawlotsky JM and Yuen MF: Chronic hepatitis B virus infection. Lancet. 392:2313–2324. 2018. View Article : Google Scholar : PubMed/NCBI

2 

Tang LSY, Covert E, Wilson E and Kottilil S: Chronic hepatitis B infection: A review. JAMA. 319:1802–1813. 2018. View Article : Google Scholar : PubMed/NCBI

3 

Tsai KN, Kuo CF and Ou JJ: Mechanisms of hepatitis B virus persistence. Trends Microbiol. 26:33–42. 2018. View Article : Google Scholar : PubMed/NCBI

4 

Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, Huang Y, Qi Y, Peng B, Wang H, et al: Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife. 1:e000492012. View Article : Google Scholar : PubMed/NCBI

5 

Chang JJ and Lewin SR: Immunopathogenesis of hepatitis B virus infection. Immunol Cell Biol. 85:16–23. 2007. View Article : Google Scholar : PubMed/NCBI

6 

Gehring AJ and Protzer U: Targeting innate and adaptive immune responses to cure chronic HBV infection. Gastroenterology. 156:325–337. 2019. View Article : Google Scholar : PubMed/NCBI

7 

Guy CS, Mulrooney-Cousins PM, Churchill ND and Michalak TI: Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus. J Virol. 82:8579–8591. 2008. View Article : Google Scholar : PubMed/NCBI

8 

Stevens KE, Thio CL and Osburn WO: CCR5 deficiency enhances hepatic innate immune cell recruitment and inflammation in a murine model of acute hepatitis B infection. Immunol Cell Biol. 97:317–325. 2019. View Article : Google Scholar : PubMed/NCBI

9 

Murray JM, Wieland SF, Purcell RH and Chisari FV: Dynamics of hepatitis B virus clearance in chimpanzees. Proc Natl Acad Sci USA. 102:17780–17785. 2005. View Article : Google Scholar : PubMed/NCBI

10 

Yang PL, Althage A, Chung J and Chisari FV: Hydrodynamic injection of viral DNA: A mouse model of acute hepatitis B virus infection. Proc Natl Acad Sci USA. 99:13825–13830. 2002. View Article : Google Scholar : PubMed/NCBI

11 

Yang PL, Althage A, Chung J, Maier H, Wieland S, Isogawa M and Chisari FV: Immune effectors required for hepatitis B virus clearance. Proc Natl Acad Sci USA. 107:798–802. 2010. View Article : Google Scholar : PubMed/NCBI

12 

Lin Y, Huang X, Wu J, Liu J, Chen M, Ma Z, Zhang E, Liu Y, Huang S, Li Q, et al: Pre-activation of toll-like receptor 2 enhances CD8+ T-cell responses and accelerates hepatitis B virus clearance in the mouse models. Front Immunol. 9:14952018. View Article : Google Scholar : PubMed/NCBI

13 

Chang WW, Su IJ, Lai MD, Chang WT, Huang W and Lei HY: The role of inducible nitric oxide synthase in a murine acute hepatitis B virus (HBV) infection model induced by hydrodynamics-based in vivo transfection of HBV-DNA. J Hepatol. 39:834–842. 2003. View Article : Google Scholar : PubMed/NCBI

14 

Golsaz-Shirazi F, Amiri MM and Shokri F: Immune function of plasmacytoid dendritic cells, natural killer cells, and their crosstalk in HBV infection. Rev Med Virol. 28:e20072018. View Article : Google Scholar : PubMed/NCBI

15 

Peeridogaheh H, Meshkat Z, Habibzadeh S, Arzanlou M, Shahi JM, Rostami S, Gerayli S and Teimourpour R: Current concepts on immunopathogenesis of hepatitis B virus infection. Virus Res. 245:29–43. 2018. View Article : Google Scholar : PubMed/NCBI

16 

Fisicaro P, Valdatta C, Boni C, Massari M, Mori C, Zerbini A, Orlandini A, Sacchelli L, Missale G and Ferrari C: Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Gut. 58:974–982. 2009. View Article : Google Scholar : PubMed/NCBI

17 

Lawand M, Déchanet-Merville J and Dieu-Nosjean MC: Key features of gamma-delta T-cell subsets in human diseases and their immunotherapeutic implications. Front Immunol. 8:7612017. View Article : Google Scholar : PubMed/NCBI

18 

Kabelitz D and Déchanet-Merville J: Editorial: ‘Recent advances in gamma/delta T cell biology: New ligands, new functions, and new translational perspectives’. Front Immunol. 6:3712015. View Article : Google Scholar : PubMed/NCBI

19 

Rajoriya N, Fergusson JR, Leithead JA and Klenerman P: Gamma delta T-lymphocytes in hepatitis C and chronic liver disease. Front Immunol. 5:4002014. View Article : Google Scholar : PubMed/NCBI

20 

Khairallah C, Netzer S, Villacreces A, Juzan M, Rousseau B, Dulanto S, Giese A, Costet P, Praloran V, Moreau JF, et al: γδ T cells confer protection against murine cytomegalovirus (MCMV). PLoS Pathog. 11:e10047022015. View Article : Google Scholar : PubMed/NCBI

21 

Howard J, Zaidi I, Loizon S, Mercereau-Puijalon O, Déchanet-Merville J and Mamani-Matsuda M: Human Vγ9Vδ2 T Lymphocytes in the Immune Response to P. falciparum Infection. Front Immunol. 9:27602018. View Article : Google Scholar : PubMed/NCBI

22 

Chen M, Zhang D, Zhen W, Shi Q, Liu Y, Ling N, Peng M, Tang K, Hu P, Hu H and Ren H: Characteristics of circulating T cell receptor gamma-delta T cells from individuals chronically infected with hepatitis B virus (HBV): An association between V(delta)2 subtype and chronic HBV infection. J Infect Dis. 198:1643–1650. 2008. View Article : Google Scholar : PubMed/NCBI

23 

Conroy MJ, Mac Nicholas R, Taylor M, O'Dea S, Mulcahy F, Norris S and Doherty DG: Increased frequencies of circulating IFN-γ-producing Vδ1(+) and Vδ2(+) γδ T cells in patients with asymptomatic persistent hepatitis B virus infection. Viral Immunol. 28:201–208. 2015. View Article : Google Scholar : PubMed/NCBI

24 

Kong X, Sun R, Chen Y, Wei H and Tian Z: γδT cells drive myeloid-derived suppressor cell-mediated CD8+ T cell exhaustion in hepatitis B virus-induced immunotolerance. J Immunol. 193:1645–1653. 2014. View Article : Google Scholar : PubMed/NCBI

25 

Huang M, Sun R, Huang Q and Tian Z: Technical improvement and application of hydrodynamic gene delivery in study of liver diseases. Front Pharmacol. 8:5912017. View Article : Google Scholar : PubMed/NCBI

26 

Li L, Li S, Zhou Y, Yang L, Zhou D, Yang Y, Lu M, Yang D and Song J: The dose of HBV genome contained plasmid has a great impact on HBV persistence in hydrodynamic injection mouse model. Virol J. 14:2052017. View Article : Google Scholar : PubMed/NCBI

27 

China National Standardization Administration, . Guidelines for the Care and Use of Laboratory Animals in China. http://www.gb688.cn/bzgk/gb/newGbInfo?hcno=9BA619057D5C13103622A10FF4BA5D14February 6–2018

28 

Duwaerts CC, Sun EP, Cheng CW, van Rooijen N and Gregory SH: Cross-activating invariant NKT cells and kupffer cells suppress cholestatic liver injury in a mouse model of biliary obstruction. PLoS One. 8:e797022013. View Article : Google Scholar : PubMed/NCBI

29 

Zhang H, Fu R, Guo C, Huang Y, Wang H, Wang S, Zhao J and Yang N: Anti-dsDNA antibodies bind to TLR4 and activate NLRP3 inflammasome in lupus monocytes/macrophages. J Transl Med. 14:1562016. View Article : Google Scholar : PubMed/NCBI

30 

Li L, Cha H, Yu X, Xie H, Wu C, Dong N and Huang J: The characteristics of NK cells in Schistosoma japonicum-infected mouse spleens. Parasitol Res. 114:4371–4379. 2015. View Article : Google Scholar : PubMed/NCBI

31 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

32 

Inatsuka C, Yang Y, Gad E, Rastetter L, Disis ML and Lu H: Gamma delta T cells are activated by polysaccharide K (PSK) and contribute to the anti-tumor effect of PSK. Cancer Immunol Immunother. 62:1335–1345. 2013. View Article : Google Scholar : PubMed/NCBI

33 

Melchjorsen J: Learning from the messengers: Innate sensing of viruses and cytokine regulation of immunity-clues for treatments and vaccines. Viruses. 5:470–527. 2013. View Article : Google Scholar : PubMed/NCBI

34 

Nosratabadi R, Alavian SM, Zare-Bidaki M, Shahrokhi VM and Arababadi MK: Innate immunity related pathogen recognition receptors and chronic hepatitis B infection. Mol Immunol. 90:64–73. 2017. View Article : Google Scholar : PubMed/NCBI

35 

Tzeng HT, Tsai HF, Chyuan IT, Liao HJ, Chen CJ, Chen PJ and Hsu PN: Tumor necrosis factor-alpha induced by hepatitis B virus core mediating the immune response for hepatitis B viral clearance in mice model. PLoS One. 9:e1030082014. View Article : Google Scholar : PubMed/NCBI

36 

Boni C, Fisicaro P, Valdatta C, Amadei B, Di Vincenzo P, Giuberti T, Laccabue D, Zerbini A, Cavalli A, Missale G, et al: Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol. 81:4215–4225. 2007. View Article : Google Scholar : PubMed/NCBI

37 

Bertoletti A and Ferrari C: Adaptive immunity in HBV infection. J Hepatol. 64 (1 Suppl):S71–S83. 2016. View Article : Google Scholar : PubMed/NCBI

38 

Yoshio S and Kanto T: Host-virus interactions in hepatitis B and hepatitis C infection. J Gastroenterol. 51:409–420. 2016. View Article : Google Scholar : PubMed/NCBI

39 

Deniger DC, Moyes JS and Cooper LJ: Clinical applications of gamma delta T cells with multivalent immunity. Front Immunol. 5:6362014. View Article : Google Scholar : PubMed/NCBI

40 

Wu YL, Ding YP, Tanaka Y, Shen LW, Wei CH, Minato N and Zhang W: γδ T cells and their potential for immunotherapy. Int J Biol Sci. 10:119–135. 2014. View Article : Google Scholar : PubMed/NCBI

41 

Paul S and Lal G: Regulatory and effector functions of gamma-delta (γδ) T cells and their therapeutic potential in adoptive cellular therapy for cancer. Int J Cancer. 139:976–985. 2016. View Article : Google Scholar : PubMed/NCBI

42 

Wang H, Luo H, Wan X, Fu X, Mao Q, Xiang X, Zhou Y, He W, Zhang J, Guo Y, et al: TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection. J Hepatol. Sep 6–2019.(Epub ahead of print). View Article : Google Scholar

43 

Wohler JE, Smith SS, Zinn KR, Bullard DC and Barnum SR: Gammadelta T cells in EAE: Early trafficking events and cytokine requirements. Eur J Immunol. 39:1516–1526. 2009. View Article : Google Scholar : PubMed/NCBI

44 

Ma Z, Ni G and Damania B: Innate sensing of DNA virus genomes. Annu Rev Virol. 5:341–362. 2018. View Article : Google Scholar : PubMed/NCBI

45 

Brubaker SW, Bonham KS, Zanoni I and Kagan JC: Innate immune pattern recognition: A cell biological perspective. Annu Rev Immunol. 33:257–290. 2015. View Article : Google Scholar : PubMed/NCBI

46 

Wieland S, Thimme R, Purcell RH and Chisari FV: Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci USA. 101:6669–6674. 2004. View Article : Google Scholar : PubMed/NCBI

47 

Tseng CT, Miskovsky E, Houghton M and Klimpel GR: Characterization of liver T-cell receptor gammadelta T cells obtained from individuals chronically infected with hepatitis C virus (HCV): Evidence for these T cells playing a role in the liver pathology associated with HCV infections. Hepatology. 33:1312–1320. 2001. View Article : Google Scholar : PubMed/NCBI

48 

Abravanel F, Barragué H, Dörr G, Sauné K, Péron JM, Alric L, Kamar N, Izopet J and Champagne E: Conventional and innate lymphocytes response at the acute phase of HEV infection in transplanted patients. J Infect. 72:723–730. 2016. View Article : Google Scholar : PubMed/NCBI

49 

Wu D, Yan WM, Wang HW, Huang D, Luo XP and Ning Q: γδ T cells contribute to the outcome of murine fulminant viral hepatitis via effector cytokines TNF-α and IFN-γ. Curr Med Sci. 38:648–655. 2018. View Article : Google Scholar : PubMed/NCBI

50 

Yoneda M, Hyun J, Jakubski S, Saito S, Nakajima A, Schiff ER and Thomas E: Hepatitis B virus and DNA stimulation trigger a rapid innate immune response through NF-κB. J Immunol. 197:630–643. 2016. View Article : Google Scholar : PubMed/NCBI

51 

Heymann F and Tacke F: Immunology in the liver-from homeostasis to disease. Nat Rev Gastroenterol Hepatol. 13:88–110. 2016. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Chang L, Wang L, Ling N, Peng H and Chen M: Increase in liver γδ T cells with concurrent augmentation of IFN‑β production during the early stages of a mouse model of acute experimental hepatitis B virus infection. Exp Ther Med 19: 67-78, 2020.
APA
Chang, L., Wang, L., Ling, N., Peng, H., & Chen, M. (2020). Increase in liver γδ T cells with concurrent augmentation of IFN‑β production during the early stages of a mouse model of acute experimental hepatitis B virus infection. Experimental and Therapeutic Medicine, 19, 67-78. https://doi.org/10.3892/etm.2019.8197
MLA
Chang, L., Wang, L., Ling, N., Peng, H., Chen, M."Increase in liver γδ T cells with concurrent augmentation of IFN‑β production during the early stages of a mouse model of acute experimental hepatitis B virus infection". Experimental and Therapeutic Medicine 19.1 (2020): 67-78.
Chicago
Chang, L., Wang, L., Ling, N., Peng, H., Chen, M."Increase in liver γδ T cells with concurrent augmentation of IFN‑β production during the early stages of a mouse model of acute experimental hepatitis B virus infection". Experimental and Therapeutic Medicine 19, no. 1 (2020): 67-78. https://doi.org/10.3892/etm.2019.8197
Copy and paste a formatted citation
x
Spandidos Publications style
Chang L, Wang L, Ling N, Peng H and Chen M: Increase in liver γδ T cells with concurrent augmentation of IFN‑β production during the early stages of a mouse model of acute experimental hepatitis B virus infection. Exp Ther Med 19: 67-78, 2020.
APA
Chang, L., Wang, L., Ling, N., Peng, H., & Chen, M. (2020). Increase in liver γδ T cells with concurrent augmentation of IFN‑β production during the early stages of a mouse model of acute experimental hepatitis B virus infection. Experimental and Therapeutic Medicine, 19, 67-78. https://doi.org/10.3892/etm.2019.8197
MLA
Chang, L., Wang, L., Ling, N., Peng, H., Chen, M."Increase in liver γδ T cells with concurrent augmentation of IFN‑β production during the early stages of a mouse model of acute experimental hepatitis B virus infection". Experimental and Therapeutic Medicine 19.1 (2020): 67-78.
Chicago
Chang, L., Wang, L., Ling, N., Peng, H., Chen, M."Increase in liver γδ T cells with concurrent augmentation of IFN‑β production during the early stages of a mouse model of acute experimental hepatitis B virus infection". Experimental and Therapeutic Medicine 19, no. 1 (2020): 67-78. https://doi.org/10.3892/etm.2019.8197
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team